Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors

OBJECTIVES: Reliable predictive biomarkers for response to immune checkpoint inhibition (ICI) are lacking. Pretreatment serum albumin, a known prognostic and predictive factor in ICI‐treated patients, has been proposed as a potential pharmacokinetic surrogate marker for anti‐PD1/PD‐L1 antibodies, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Saal, Jonas, Ellinger, Jörg, Ritter, Manuel, Brossart, Peter, Hölzel, Michael, Klümper, Niklas, Bald, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632074/
https://www.ncbi.nlm.nih.gov/pubmed/37946873
http://dx.doi.org/10.1002/cti2.1472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632074/
https://www.ncbi.nlm.nih.gov/pubmed/37946873
http://dx.doi.org/10.1002/cti2.1472

Ejemplares similares